欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4874/001
药品名称Sorafenib PharOS 200 mg
活性成分
    • SORAFENIB TOSILATE 200.0 mg
剂型Film-coated tablet
上市许可持有人PharOS Pharmaceutical Oriented Services Limited Lesvou Street End, Thesi Loggos, Industrial Zone Metamorfossi 144 52 Greece
参考成员国 - 产品名称Netherlands (NL)
Sorafenib PharOS 200 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Sorafenib PharOS 200 mg Filmtabletten
    • Denmark (DK)
    • Iceland (IS)
    • Austria (AT)
      Sorafenib STADA 200 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Sorafenib Stada
    • Hungary (HU)
    • Czechia (CZ)
      Sorafenib PharOS
    • Romania (RO)
      Sorafenib PharOS 200 mg comprimate filmate
    • Slovakia (SK)
      Sorafenib STADA
    • Croatia (HR)
    • Belgium (BE)
    • Luxembourg (LU)
    • Norway (NO)
许可日期2020/06/03
最近更新日期2024/01/02
药物ATC编码
    • L01XE05 sorafenib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase